Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The technetium Tc-99m generator is a lead-shielded medical device used in nuclear medicine to produce technetium-99m (Tc-99m), the most widely utilized radioisotope for diagnostic imaging. It operates as a parent-daughter decay system, where the parent isotope molybdenum-99 (Mo-99) is adsorbed onto an alumina (aluminum oxide) column. Mo-99, which has a half-life of approximately 66 hours, decays into the daughter isotope Tc-99m, which has a half-life of about 6 hours. The Tc-99m is extracted by eluting the column with a sterile 0.9% sodium chloride solution, yielding a solution of sodium pertechnetate Tc-99m. This eluate can be used directly for imaging certain organs or as a precursor to radiolabel various diagnostic kits. The generator is essential for providing a reliable, on-site source of Tc-99m for procedures including myocardial perfusion imaging, bone scintigraphy, and renal, brain, and lung scans.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on technetium Tc-99m generator.